Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II.
about
GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonistExploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.
P2860
Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Powerful inhibition of in-vivo ...... peptide antagonist RC-3940-II.
@en
Powerful inhibition of in-vivo ...... peptide antagonist RC-3940-II.
@nl
type
label
Powerful inhibition of in-vivo ...... peptide antagonist RC-3940-II.
@en
Powerful inhibition of in-vivo ...... peptide antagonist RC-3940-II.
@nl
prefLabel
Powerful inhibition of in-vivo ...... peptide antagonist RC-3940-II.
@en
Powerful inhibition of in-vivo ...... peptide antagonist RC-3940-II.
@nl
P2093
P50
P1433
P1476
Powerful inhibition of in-vivo ...... peptide antagonist RC-3940-II.
@en
P2093
Irving Vidaurre
Luca Szalontay
Norman L Block
P304
P356
10.1097/CAD.0B013E328354BD25
P577
2012-10-01T00:00:00Z